mRNA Vaccine Market Size By Application, Industry Analysis Report, Regional Outlook (North America, Europe, Asia Pacific, Middle East & Africa, And South America), Growth Potential, Price Trends, Competitive Market Share & Forecast 2023 - 2030 (Financial Impact Analysis)
ID : MRU_
4235 | Date :
Jan, 2023 | Pages :
180 | Region : Global |
Publisher : 99 Strategy
mRNA is a rather versatile technology and offers a number of advantages. mRNA lacks genomic integration and its use results in transient expression of the encoded protein. This favorable safety profile makes mRNA especially attractive for vaccines and gene editing. mRNA is well defined chemically which ensures reproducible manufacturing at high yield, purity and activity. Improvements of lipid nanoparticle formulations as a vehicle for in vivo systemic delivery of mRNA has greatly favored the development of in vivo transfection strategies.
The Global mRNA Vaccine Market touched xxx million USD with a CAGR xx % from 2018-2022 around the world. In the future, it is predicted to reach xxx million USD in 2023 with a CAGR xx % from 2023-2030.
As the report focuses on global mRNA Vaccine Market, mainly in Europe and Asia Pacific, North America, Middle East and Africa, and South America. This report segmented the Market on the basis of regions, manufacturers, applications, and type.
in addition, this report introduces Market competition situation among the vendors and company profile, besides, Market price analysis and value chain features are covered in this report.
In Market segmentation by manufacturers, the report covers the following companies-
Moderna Therapeutics
CureVac
Translate Bio
BioNTech
Sangamo Therapeutics
Argos Therapeutics
In-Cell-Art
eTheRNA
Ethris
Tiba Biotechnology
In Market segmentation by geographical regions, the report has analyzed the following regions- North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Columbia etc.) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
In Market segmentation by types covers:
Standardization Of Cancer Treatment MRNA Vaccine
Individualized Cancer Treatment MRNA Vaccine
Infectious Disease Treatment MRNA Vaccine
Infection Prevention MRNA Vaccine
In Market segmentation by applications :
Infectious Disease
Cancer
Other
Apart from the drivers, restraints, and opportunities, the report also offers competitive landscape, including various growth strategies adopted by profiled players for establishing significant position in the industry. The segmentation included in the comprehensive report will help respectable manufacturers to set up their processing units in the regions and increase their global presence. This would also benefit the industry and increase the company\'s product portfolio.
The research provides answers to the following key questions:
• What is the estimated growth rate and Market share and size of the mRNA Vaccine Market for the forecast period 2023-2030?
• What are the driving forces in the mRNA Vaccine Market for the forecast period 2023-2030?
• Who are the prominent Market players and how have they gained a competitive edge over other competitors?
• What are the Market trends influencing the progress of the mRNA Vaccine industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the Market hold for the prominent Market players? Any special requirements about this report, please let us know and we can provide custom report.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global mRNA Vaccine Market Size Growth Rate by Type (2020-2030)
1.3.2 Standardization Of Cancer Treatment MRNA Vaccine
1.3.3 Individualized Cancer Treatment MRNA Vaccine
1.3.4 Infectious Disease Treatment MRNA Vaccine
1.3.5 Infection Prevention MRNA Vaccine
1.4 Market Segment by Application
1.4.1 Global mRNA Vaccine Market Share by Application (2020-2030)
1.4.2 Infectious Disease
1.4.3 Cancer
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Vaccine Market Size
2.1.1 Global mRNA Vaccine Revenue 2015-2030
2.1.2 Global mRNA Vaccine Sales 2015-2030
2.2 mRNA Vaccine Growth Rate by Regions
2.2.1 Global mRNA Vaccine Sales by Regions 2018 - 2022
2.2.2 Global mRNA Vaccine Revenue by Regions 2018 - 2022
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 mRNA Vaccine Sales by Manufacturers
3.1.1 mRNA Vaccine Sales by Manufacturers 2018 - 2022
3.1.2 mRNA Vaccine Sales Market Share by Manufacturers 2018 - 2022
3.2 Revenue by Manufacturers
3.2.1 mRNA Vaccine Revenue by Manufacturers (2018 - 2022)
3.2.2 mRNA Vaccine Revenue Share by Manufacturers (2018 - 2022)
3.2.3 Global mRNA Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 mRNA Vaccine Price by Manufacturers
3.4 Key Manufacturers mRNA Vaccine Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into mRNA Vaccine Market
3.6 Key Manufacturers mRNA Vaccine Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Standardization Of Cancer Treatment MRNA Vaccine Sales and Revenue (2018 - 2022)
4.1.2 Individualized Cancer Treatment MRNA Vaccine Sales and Revenue (2018 - 2022)
4.1.3 Infectious Disease Treatment MRNA Vaccine Sales and Revenue (2018 - 2022)
4.1.4 Infection Prevention MRNA Vaccine Sales and Revenue (2018 - 2022)
4.2 Global mRNA Vaccine Sales Market Share by Type
4.3 Global mRNA Vaccine Revenue Market Share by Type
4.4 mRNA Vaccine Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global mRNA Vaccine Sales by Application
6 United States
6.1 United States mRNA Vaccine Breakdown Data by Company
6.2 United States mRNA Vaccine Breakdown Data by Type
6.3 United States mRNA Vaccine Breakdown Data by Application
7 European Union
7.1 European Union mRNA Vaccine Breakdown Data by Company
7.2 European Union mRNA Vaccine Breakdown Data by Type
7.3 European Union mRNA Vaccine Breakdown Data by Application
8 China
8.1 China mRNA Vaccine Breakdown Data by Company
8.2 China mRNA Vaccine Breakdown Data by Type
8.3 China mRNA Vaccine Breakdown Data by Application
9 Rest of World
9.1 Rest of World mRNA Vaccine Breakdown Data by Company
9.2 Rest of World mRNA Vaccine Breakdown Data by Type
9.3 Rest of World mRNA Vaccine Breakdown Data by Application
9.4 Rest of World mRNA Vaccine Breakdown Data by Countries
9.4.1 Rest of World mRNA Vaccine Sales by Countries
9.4.2 Rest of World mRNA Vaccine Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Moderna Therapeutics
10.1.1 Moderna Therapeutics Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of mRNA Vaccine
10.1.4 mRNA Vaccine Product Introduction
10.1.5 Moderna Therapeutics Recent Development
10.2 CureVac
10.2.1 CureVac Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of mRNA Vaccine
10.2.4 mRNA Vaccine Product Introduction
10.2.5 CureVac Recent Development
10.3 Translate Bio
10.3.1 Translate Bio Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of mRNA Vaccine
10.3.4 mRNA Vaccine Product Introduction
10.3.5 Translate Bio Recent Development
10.4 BioNTech
10.4.1 BioNTech Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of mRNA Vaccine
10.4.4 mRNA Vaccine Product Introduction
10.4.5 BioNTech Recent Development
10.5 Sangamo Therapeutics
10.5.1 Sangamo Therapeutics Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of mRNA Vaccine
10.5.4 mRNA Vaccine Product Introduction
10.5.5 Sangamo Therapeutics Recent Development
10.6 Argos Therapeutics
10.6.1 Argos Therapeutics Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of mRNA Vaccine
10.6.4 mRNA Vaccine Product Introduction
10.6.5 Argos Therapeutics Recent Development
10.7 In-Cell-Art
10.7.1 In-Cell-Art Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of mRNA Vaccine
10.7.4 mRNA Vaccine Product Introduction
10.7.5 In-Cell-Art Recent Development
10.8 eTheRNA
10.8.1 eTheRNA Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of mRNA Vaccine
10.8.4 mRNA Vaccine Product Introduction
10.8.5 eTheRNA Recent Development
10.9 Ethris
10.9.1 Ethris Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of mRNA Vaccine
10.9.4 mRNA Vaccine Product Introduction
10.9.5 Ethris Recent Development
10.10 Tiba Biotechnology
10.10.1 Tiba Biotechnology Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of mRNA Vaccine
10.10.4 mRNA Vaccine Product Introduction
10.10.5 Tiba Biotechnology Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 mRNA Vaccine Sales Channels
11.2.2 mRNA Vaccine Distributors
11.3 mRNA Vaccine Customers
12 Market Forecast
12.1 Global mRNA Vaccine Sales and Revenue Forecast 2020-2030
12.2 Global mRNA Vaccine Sales Forecast by Type
12.3 Global mRNA Vaccine Sales Forecast by Application
12.4 mRNA Vaccine Forecast by Regions
12.4.1 Global mRNA Vaccine Sales Forecast by Regions 2020-2030
12.4.2 Global mRNA Vaccine Revenue Forecast by Regions 2020-2030
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
Research Methodology
The Market Research Update offers technology-driven solutions and its full integration in the research process to be skilled at every step. We use diverse assets to produce the best results for our clients. The success of a research project is completely reliant on the research process adopted by the company. Market Research Update assists its clients to recognize opportunities by examining the global market and offering economic insights. We are proud of our extensive coverage that encompasses the understanding of numerous major industry domains.
Market Research Update provide consistency in our research report, also we provide on the part of the analysis of forecast across a gamut of coverage geographies and coverage. The research teams carry out primary and secondary research to implement and design the data collection procedure. The research team then analyzes data about the latest trends and major issues in reference to each industry and country. This helps to determine the anticipated market-related procedures in the future. The company offers technology-driven solutions and its full incorporation in the research method to be skilled at each step.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
We are flexible and responsive startup research firm. We adapt as your research requires change, with cost-effectiveness and highly researched report that larger companies can't match.
Information Safety
Market Research Update ensure that we deliver best reports. We care about the confidential and personal information quality, safety, of reports. We use Authorize secure payment process.
We Are Committed to Quality and Deadlines
We offer quality of reports within deadlines. We've worked hard to find the best ways to offer our customers results-oriented and process driven consulting services.
Our Remarkable Track Record
We concentrate on developing lasting and strong client relationship. At present, we hold numerous preferred relationships with industry leading firms that have relied on us constantly for their research requirements.
Best Service Assured
Buy reports from our executives that best suits your need and helps you stay ahead of the competition.
Customized Research Reports
Our research services are custom-made especially to you and your firm in order to discover practical growth recommendations and strategies. We don't stick to a one size fits all strategy. We appreciate that your business has particular research necessities.
Service Assurance
At Market Research Update, we are dedicated to offer the best probable recommendations and service to all our clients. You will be able to speak to experienced analyst who will be aware of your research requirements precisely.
